Literature DB >> 1109179

Uterine prostaglandin E secretion and uterine blood flow in the pregnant rabbit.

R C Venuto, T O'Dorisio, J H Stein, T F Ferris.   

Abstract

Studies were performed in pregnant rabbits to assess the effect of inhibition of prostaglandin synthesis on uterine blood flow. Cardiac output and uteroplacental blood flow (UPBF) were measured using radiolabeled microspheres. Prostaglandin E (PGE) concentration was measured by radioimmunoassay in the uterine vein and peripheral artery of the pregnant nephrectomized rabbit. Either meclofenamate or indomethacin 2 mg/kg were utilized to inhibit prostaglandin synthesis. Systemic arterial pressure increased from 86 mm Hg to 98 mm Hg (P less than0.0001) after prostaglandin inhibition. Cardiac output was unchanged after the inhibition of prostaglandin synthesis, 326 ml/min to 7.8 ml/min. Uterine vein PGE concentration was extremely high, 172.4 ng/ml, with concomitant peripheral arterial PGE 2.1 NG/ML. Intravenous administration of either meclofenamate or indomethacin reduced uterine vein PGE to 23 ng/ml (P less than 0.01) and arterial PGE to 1.0 ng/ml (P less than 0.05). Male and nonpregnant female rabbits had lower arterial PGE, 0.37 ng/ml (P less 0.05). Studies in non-nephrectomized pregnant animals demonstrated that uteroplacental secretion of PGE was greater than five times renal secretion. These studies demonstrate that the rabbit uteroplacental unit is a rich source of PGE and suggest that production of the vasoactive lipid may have a key role in regulating UPBF during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1109179      PMCID: PMC301732          DOI: 10.1172/JCI107911

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  PROSTAGLANDINS IN ENDOMETRIUM AND MENSTRUAL FLUID FROM NORMAL AND DYSMENORRHOEIC SUBJECTS.

Authors:  V R PICKLES; W J HALL; F A BEST; G N SMITH
Journal:  J Obstet Gynaecol Br Commonw       Date:  1965-04

2.  Prostaglandins and the regulation of uterine blood flow in pregnancy.

Authors:  N A Terragno; D A Terragno; D Pacholczyk; J C McGiff
Journal:  Nature       Date:  1974-05-03       Impact factor: 49.962

3.  A study of angiotensin II pressor response throughout primigravid pregnancy.

Authors:  N F Gant; G L Daley; S Chand; P J Whalley; P C MacDonald
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

Review 4.  Toxemia of pregnancy. Mechanism and therapeutic management.

Authors:  L Speroff
Journal:  Am J Cardiol       Date:  1973-09-20       Impact factor: 2.778

5.  Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin.

Authors:  J W Aiken; J R Vane
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

6.  Uterine blood flow and uterine renin secretion.

Authors:  T F Ferris; J H Stein; J Kauffman
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

Review 7.  Biological significance of the prostaglandins.

Authors:  P W Ramwell; J E Shaw
Journal:  Recent Prog Horm Res       Date:  1970

8.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

9.  Selective passage of prostaglandins across the lung.

Authors:  J C McGiff; N A Terragno; J C Strand; J B Lee; A J Lonigro; K K Ng
Journal:  Nature       Date:  1969-08-16       Impact factor: 49.962

10.  Effect of prostaglandins E 1 , E 2 and A 2 on vascular resistance and responses to noradrenaline, nerve stimulation and angiotensin in the dog hindlimb.

Authors:  P J Kadowitz
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

View more
  12 in total

1.  The effect of changes in perfusion pressure on uteroplacental blood flow in the pregnant rabbit.

Authors:  R C Venuto; J W Cox; J H Stein; T F Ferris
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

2.  Regulation of the Ca(2+)-independent phospholipase A2 in liver mitochondria by changes in the energetic state.

Authors:  Adam J Rauckhorst; Kimberly M Broekemeier; Douglas R Pfeiffer
Journal:  J Lipid Res       Date:  2014-03-01       Impact factor: 5.922

3.  Toxemia and hypertension during pregnancy.

Authors:  T F Ferris; L L Francisco
Journal:  Bull N Y Acad Med       Date:  1982-03

4.  Control of diabetes during pregnancy using continuous insulin infusion.

Authors:  C Q Edwards; R B Cannon; P J Haug; K W Farnsworth
Journal:  West J Med       Date:  1982-03

5.  Indomethacin modulation of adriamycin-induced effects on multiple cytolytic effector functions.

Authors:  D L Maccubbin; S A Cohen; M J Ehrke
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

6.  The modulation of enhanced vascular permeability by prostaglandins through alterations in blood flow (hyperemia).

Authors:  M G Johnston; J B Hay; H Z Movat
Journal:  Agents Actions       Date:  1976-11

7.  Indomethacin is a placental vasodilator in the dog. The effect of prostaglandin inhibition.

Authors:  J G Gerber; R A Branch; W C Hubbard; A S Nies
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

8.  Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy. Serial studies in chronically instrumented, conscious rats.

Authors:  K P Conrad; M C Colpoys
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

9.  The response of the hind-limb vascular bed of the rabbit to sympathetic stimulation and its modification by pregnancy.

Authors:  P W Humphreys; N Joels
Journal:  J Physiol       Date:  1982-09       Impact factor: 5.182

10.  Effect of captopril on uterine blood flow and prostaglandin E synthesis in the pregnant rabbit.

Authors:  T F Ferris; E K Weir
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.